Medical Institution Bankruptcies Reach 16-Year High as “Zero

News Highlights

According to a Nikkei report on August 13, 2025, the number of bankruptcies among medical institutions has reached a 16-year high. This is reportedly due to the full-scale commencement of repayments for the “zero-zero loans” (interest-free, unsecured loans) introduced during the COVID-19 pandemic. The analysis suggests that a decline in management indicators, such as a worsening current ratio and consecutive years of operating losses, has led to an increase in bankruptcies.

M&A Medical Editorial Perspective

We are keenly feeling the shift in the healthcare institution management landscape, indicated by the full-scale repayment of “zero-zero loans,” here at M&A Medical, the front lines of M&A and business succession. In particular, in regional clinics and small to medium-sized hospitals, where cash flow temporarily improved during the pandemic but subsequent revenue recovery has been slow, we are seeing cases where the burden of loan repayments is beginning to strain management. If loan repayments falter, leading to unavoidable closures, not only will there be a void in regional healthcare, but there’s also the risk of the clinic director being left with personal joint and several liability for the debt. By considering M&A at an early stage and transferring the patient base and staff employment through a business transfer scheme, the possibility of avoiding these risks and smoothly proceeding with the director’s personal debt settlement increases significantly. The current surge in bankruptcies can be seen as a clear sign to return to the fundamental principle of M&A brokerage: “before it’s too late.”.

Points Raised by This News

• The full-scale repayment of “zero-zero loans” is acting as a trigger, increasing bankruptcies among financially distressed medical institutions.
• A worsening current ratio and consecutive years of operating losses are indicated as specific management indicators that heighten bankruptcy risk.
• Closures create a void in regional healthcare and leave the clinic director with personal debt risks, but succession through M&A offers a path to avoid these issues.
• The diminishing effect of improved cash flow during the pandemic is becoming apparent, with actual management pressures starting to materialize.

Practical Questions Arising from This News

• Specifically, which management indicators deteriorate and increase bankruptcy risk when “zero-zero loan” repayments begin?
• What alternative options exist besides M&A when loan repayments become difficult?
• What schemes can be considered to settle the clinic director’s personal debt while minimizing the impact on regional healthcare?

If You Feel “Should I Consult?”

If your institution finds the repayment of “zero-zero loans” burdensome, or if you have experienced a worsening current ratio or operating losses for the past few years, please consult with a specialist. Before reaching the point of closure, you may find a path to protect your patients, staff, and your own future through business succession via M&A. Early consultation can lead to a succession under more favorable terms.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution, with a full success fee basis. Consultations are handled with strict confidentiality. Free consultations here